Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler (Q34505507)

2 August 2017

title

Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler (English)

1 reference

2 August 2017

0 references

Bernstein DI

1

1 reference

2 August 2017

Berkowitz RB

2

1 reference

2 August 2017

Chervinsky P

3

1 reference

2 August 2017

Dvorin DJ

4

1 reference

2 August 2017

Finn AF

5

1 reference

2 August 2017

Gross GN

6

1 reference

2 August 2017

Karetzky M

7

1 reference

2 August 2017

Kemp JP

8

1 reference

2 August 2017

Laforce C

9

1 reference

2 August 2017

Lumry W

10

1 reference

2 August 2017

Mendelson LM

11

1 reference

2 August 2017

Nelson H

12

1 reference

2 August 2017

Pearlman D

13

1 reference

2 August 2017

Rachelefsky G

14

1 reference

2 August 2017

Ratner P

15

1 reference

2 August 2017

Repsher L

16

1 reference

2 August 2017

Segal AT

17

1 reference

2 August 2017

Selner JC

18

1 reference

2 August 2017

Settipane GA

19

1 reference

2 August 2017

Wanderer A

20

1 reference

2 August 2017

Cuss FM

21

1 reference

2 August 2017

Nolop KB

22

1 reference

2 August 2017

Harrison JE

23

1 reference

2 August 2017

publication date

1 September 1999

1 reference

2 August 2017

1 reference

2 August 2017

volume

93

1 reference

2 August 2017

issue

9

1 reference

2 August 2017

page(s)

603-612

1 reference

A comparison of the efficacy and safety of inhaled corticosteroids in asthma

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990099-9

7 January 2021

Dose-response effect for adrenal suppression with repeated twice daily inhaled fluticasone propionate and triamcinolone acetonide in adult asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990099-9

7 January 2021

Adverse effects of inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990099-9

7 January 2021

A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990099-9

7 January 2021

Once daily mometasone furoate aqueous nasal spray is as effective as twice daily beclomethasone dipropionate for treating perennial allergic rhinitis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990099-9

7 January 2021

The inhibitory effects of topically active glucocorticoids on IL-4, IL-5, and interferon-gamma production by cultured primary CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990099-9

7 January 2021

Glucocorticoids inhibit proliferation and interleukin-4 and interleukin-5 secretion by aeroallergen-specific T-helper type 2 cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990099-9

7 January 2021

Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. The Fluticasone Propionate Asthma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990099-9

7 January 2021

Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990099-9

7 January 2021

A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990099-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990099-9

7 January 2021

Comparison of dose-response effects of inhaled beclomethasone dipropionate and budesonide in the management of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990099-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990099-9

7 January 2021

Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990099-9

7 January 2021

A comparative study of the effects of intranasal triamcinolone acetonide aerosol (ITAA) and prednisone on adrenocortical function

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990099-9

7 January 2021

Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990099-9

7 January 2021

Oral glucocorticosteroid-sparing effect of budesonide administered by Turbuhaler: a double-blind, placebo-controlled study in adults with moderate-to-severe chronic asthma. Pulmicort Turbuhaler Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990099-9

7 January 2021

10.1016/S0954-6111(99)90099-9

Identifiers

DOI

1 reference

2 August 2017

1 reference